- Home
- COGT vs MAX Comparison
COGT vs MAX Comparison
Compare COGT & MAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- MAX
- Stock Information
- Founded
- COGT 2014
- MAX 2014
- Country
- COGT United States
- MAX United States
- Employees
- COGT N/A
- MAX N/A
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- MAX Industrial Machinery/Components
- Sector
- COGT Health Care
- MAX Industrials
- Exchange
- COGT Nasdaq
- MAX Nasdaq
- Market Cap
- COGT 555.6M
- MAX 582.4M
- IPO Year
- COGT 2018
- MAX 2020
- Fundamental
- Price
- COGT $5.44
- MAX $10.19
- Analyst Decision
- COGT Buy
- MAX Buy
- Analyst Count
- COGT 6
- MAX 7
- Target Price
- COGT $15.20
- MAX $17.21
- AVG Volume (30 Days)
- COGT 1.2M
- MAX 463.2K
- Earning Date
- COGT 05-06-2025
- MAX 04-30-2025
- Dividend Yield
- COGT N/A
- MAX N/A
- EPS Growth
- COGT N/A
- MAX N/A
- EPS
- COGT N/A
- MAX 0.28
- Revenue
- COGT N/A
- MAX $1,002,364,000.00
- Revenue This Year
- COGT N/A
- MAX $23.97
- Revenue Next Year
- COGT N/A
- MAX $9.79
- P/E Ratio
- COGT N/A
- MAX $36.80
- Revenue Growth
- COGT N/A
- MAX 148.62
- 52 Week Low
- COGT $3.72
- MAX $7.33
- 52 Week High
- COGT $12.61
- MAX $20.91
- Technical
- Relative Strength Index (RSI)
- COGT 56.27
- MAX 56.36
- Support Level
- COGT $4.80
- MAX $9.79
- Resistance Level
- COGT $4.99
- MAX $10.60
- Average True Range (ATR)
- COGT 0.31
- MAX 0.31
- MACD
- COGT 0.07
- MAX -0.03
- Stochastic Oscillator
- COGT 88.56
- MAX 41.98
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
About MAX MediaAlpha Inc.
MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.